[go: up one dir, main page]

WO2002063009A8 - Lp mammalian proteins; related reagents - Google Patents

Lp mammalian proteins; related reagents

Info

Publication number
WO2002063009A8
WO2002063009A8 PCT/US2002/000525 US0200525W WO02063009A8 WO 2002063009 A8 WO2002063009 A8 WO 2002063009A8 US 0200525 W US0200525 W US 0200525W WO 02063009 A8 WO02063009 A8 WO 02063009A8
Authority
WO
WIPO (PCT)
Prior art keywords
mammalian proteins
related reagents
reagents
reagentsand
polypeptidesspecific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2002/000525
Other languages
French (fr)
Other versions
WO2002063009A3 (en
WO2002063009A2 (en
Inventor
Ramesh Rajani Bhatt
John Nels Calley
Josef Georg Heuer
Gerald Patrick Keleher
Joanne Sloan Lancaster
Qingqin Li
Deshun Lu
Bradley Jay Mills
Santosh Kumar Mishra
Douglas Raymond Perkins
Scott William Rowlinson
Rosamund Carol Smith
Eric Wen Su
He Wang
Yu Zhi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Priority to AU2002249928A priority Critical patent/AU2002249928A1/en
Priority to US10/470,390 priority patent/US20040126777A1/en
Priority to EP02718810A priority patent/EP1419250A2/en
Publication of WO2002063009A2 publication Critical patent/WO2002063009A2/en
Anticipated expiration legal-status Critical
Publication of WO2002063009A3 publication Critical patent/WO2002063009A3/en
Publication of WO2002063009A8 publication Critical patent/WO2002063009A8/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Isolated nucleic acid molecules encoding polypeptides froma human, reagents related thereto (including purified polypeptidesspecific antibodies) are provided. Methods of using said reagentsand diagnostic kits are also provided.
PCT/US2002/000525 2001-02-02 2002-01-28 Lp mammalian proteins; related reagents Ceased WO2002063009A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2002249928A AU2002249928A1 (en) 2001-02-02 2002-01-28 Lp mammalian proteins; related reagents
US10/470,390 US20040126777A1 (en) 2002-01-28 2002-01-28 Lp mammalian proteins; related reagents
EP02718810A EP1419250A2 (en) 2001-02-02 2002-01-28 Lp mammalian proteins; related reagents

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US26635901P 2001-02-02 2001-02-02
US60/266,359 2001-02-02
US27056401P 2001-02-21 2001-02-21
US60/270,564 2001-02-21
US30505801P 2001-07-13 2001-07-13
US60/305,058 2001-07-13

Publications (3)

Publication Number Publication Date
WO2002063009A2 WO2002063009A2 (en) 2002-08-15
WO2002063009A3 WO2002063009A3 (en) 2004-03-18
WO2002063009A8 true WO2002063009A8 (en) 2004-04-22

Family

ID=27401883

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/000525 Ceased WO2002063009A2 (en) 2001-02-02 2002-01-28 Lp mammalian proteins; related reagents

Country Status (3)

Country Link
EP (1) EP1419250A2 (en)
AU (1) AU2002249928A1 (en)
WO (1) WO2002063009A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002250143A1 (en) * 2001-03-16 2002-10-03 Eli Lilly And Company Lp mammalian proteins; related reagents
US7745585B2 (en) 2003-09-02 2010-06-29 Boehringer Ingelheim International Gmbh Antibodies to interleukin-like epithelial-mesenchymal transition inducer (ILEI)
WO2014097978A1 (en) * 2012-12-19 2014-06-26 国立大学法人滋賀医科大学 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND/OR PREVENTION OF DISEASE INVOLVING ABNORMAL ACCUMULATION OF AMYLOID β PROTEIN

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993000353A1 (en) * 1991-06-20 1993-01-07 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Sequences characteristic of human gene transcription product

Also Published As

Publication number Publication date
WO2002063009A3 (en) 2004-03-18
AU2002249928A1 (en) 2002-08-19
WO2002063009A2 (en) 2002-08-15
EP1419250A2 (en) 2004-05-19

Similar Documents

Publication Publication Date Title
WO2002020569A3 (en) Mammalian genes; related reagents and methods
EP2100959A3 (en) Mammalian cytokine: interleukin-B30 and related reagents
WO2004033631A8 (en) Nucleic acid and polypeptide sequences from lawsonia intracellularis and methods of using
EP1897949A3 (en) Human interleukin-B50. Therapeutic uses
WO2000042188A3 (en) Interleukin-17 related mammalian cytokines. polynucleotides encoding them. uses
WO1998001557A3 (en) Mammalian chemokine reagents
WO2003020005A3 (en) Lp mammalian proteins; related reagents
EP1942114A3 (en) Mammalian cytokines; related reagents and methods
WO1998011226A3 (en) Mammalian chemokines, related reagents
WO1998023750A3 (en) Mammalian chemokines
WO1999003993A3 (en) Suppressors of cytokine signaling; related reagents
WO1998039421A3 (en) Mammalian proteinases; oxidoreductases; gtp binding proteins; related reagents
WO1998032858A3 (en) Mammalian chemokines; receptors; reagents; uses
WO2002074906A3 (en) Lp mammalian proteins; related reagents
WO2002068596A3 (en) Mammalian cytokines; related reagents
WO2001064713A3 (en) Mammalian interleukin-10 (il-10) receptor variants
WO2002063009A3 (en) Lp mammalian proteins; related reagents
WO2002026929A3 (en) Kini-3 motor protein and methods for its use
WO1999047673A3 (en) Isolated mammalian membrane protein genes and related reagents
WO2003012120A3 (en) Lp354 mammalian secreted protein
WO1998031810A3 (en) Mammalian chemokines; receptors; reagents; uses
EP0997476A3 (en) Antibodies to a mammalian Langerhans cell antigen and their uses
WO2002033084A3 (en) Identification of the dombrock blood group glycoprotein as a polymorphic member of the adp-ribosyltransferase gene family
WO2003022992A3 (en) Mammalian genes; related reagents
WO2002012541A3 (en) Novel motor proteins and methods for their use

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 10470390

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2002718810

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 33/2002 DUE TO A TECHNICAL PROBLEMAT THE TIME OF INTERNATIONAL PUBLICATION, SOME INFORMATION WAS MISSING UNDER (81). THE MISSING INFORMATION NOW APPEARS IN THE CORRECTED VERSION

WWP Wipo information: published in national office

Ref document number: 2002718810

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2002718810

Country of ref document: EP

NENP Non-entry into the national phase in:

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP